The Zacks Investment Research Lowered Galena Biopharma Inc. (GALE) to Hold

Posted under Uncategorized on December 10th, 2016 by

The biotechnology company reported $0.05 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.06) by …

Leave a Comment